Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Spontaneous cerebrospinal fluid rhinorrhea associated with a far lateral temporal encephalocele--case report.

Arai A., Mizukawa K., Nishihara M., Fujita A., Hosoda K., Kohmura E.

Case Report / Series on Autoimmune Research, published in Neurol Med Chir (Tokyo) (2010) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Neurol Med Chir (Tokyo) (2010)
Country
Japan
Reported sample size
—
Source database
PubMed
PMID
20339278
DOI
10.2176/nmc.50.243

Abstract (original English)

A 35-year-old female complained of right-sided watery nasal discharge persisting for 2 weeks. Neuroimaging investigations revealed a defect in the lateral side of middle cranial fossa, temporal lobe encephalocele protruding into the lateral extension of the sphenoid sinus, and cerebrospinal fluid (CSF) collection on the right side of the sphenoid sinus. The transcranial approach was performed for resection of the encephalocele and obliteration of the cranial base defect anterolateral to the foramen spinosum with transcranial multilayered closure of the defect using autologous fat, cranial bone graft, and vascularized split temporal muscle. At 1-year follow up, the CSF rhinorrhea had not recurred. Transcranial multilayered closure of the defect is safe and reliable, particularly for large CSF fistula at the far lateral sphenoid sinus.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdultBone TransplantationCerebrospinal Fluid RhinorrheaEncephaloceleFemaleHumansNeurosurgical ProceduresRadiographySkull Base

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research